Literature DB >> 1500709

Lymphoblastoid interferon in chronic hepatitis C patients, 'non-responders' to recombinant interferon-alpha (rIFN-alpha)

L Cimino, C Citarella, G Nardone, G Budillon.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1500709     DOI: 10.1016/0168-8278(92)90205-4

Source DB:  PubMed          Journal:  J Hepatol        ISSN: 0168-8278            Impact factor:   25.083


× No keyword cloud information.
  2 in total

Review 1.  Risks and benefits of interferon-alpha in the treatment of hepatitis.

Authors:  M Pardo; E Marriott; M C Moliner; J A Quiroga; V Carreño
Journal:  Drug Saf       Date:  1995-11       Impact factor: 5.606

2.  Serum interferon (IFN)-neutralizing antibodies and bioactivities of IFNs in patients with severe type II essential mixed cryoglobulinemia.

Authors:  Carolina Scagnolari; Milvia Casato; Francesca Bellomi; Francesca De Pisa; Ombretta Turriziani; Rossella Coviello; Maria Rosaria Pirro; Ferdinando Dianzani; Guido Antonelli
Journal:  Clin Diagn Lab Immunol       Date:  2003-01
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.